Global CD27 Antibody Market Growth 2022-2028
CD27 antibody is an unconjugated antibody toCD27.
The global market for CD27 Antibody is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC CD27 Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States CD27 Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe CD27 Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China CD27 Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key CD27 Antibody players cover Sino Biological, Inc., LifeSpan BioSciences, Inc, BioLegend, Thermo Fisher Scientific (China) Co., Ltd. and Abcam, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global CD27 Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global CD27 Antibody market, with both quantitative and qualitative data, to help readers understand how the CD27 Antibody market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the CD27 Antibody market and forecasts the market size by Type (Monoclonal Antibody and Polyclonal Antibody,), by Application (Flow Cytometry, ELISA, Western Blot and Immunoprecipitation), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Monoclonal Antibody
Polyclonal Antibody
Segmentation by application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sino Biological, Inc.
LifeSpan BioSciences, Inc
BioLegend
Thermo Fisher Scientific (China) Co., Ltd.
Abcam
Bio-Techne
MyBiosource, Inc.
Merck
Bio-Rad Laboratories, Inc.
Arigo Biolaboratories Corp.
GeneTex
Boster Biological Technology
Creative Diagnostics
OriGene Technologies, Inc.
Elabscience Biotechnology Inc.
Chapter Introduction
Chapter 1: Scope of CD27 Antibody, Research Methodology, etc.
Chapter 2: Executive Summary, global CD27 Antibody market size (sales and revenue) and CAGR, CD27 Antibody market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: CD27 Antibody sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global CD27 Antibody sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global CD27 Antibody market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Sino Biological, Inc., LifeSpan BioSciences, Inc, BioLegend, Thermo Fisher Scientific (China) Co., Ltd., Abcam, Bio-Techne, MyBiosource, Inc., Merck and Bio-Rad Laboratories, Inc., etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CD27 Antibody Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for CD27 Antibody by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for CD27 Antibody by Country/Region, 2017, 2022 & 2028
2.2 CD27 Antibody Segment by Type
2.2.1 Monoclonal Antibody
2.2.2 Polyclonal Antibody
2.3 CD27 Antibody Sales by Type
2.3.1 Global CD27 Antibody Sales Market Share by Type (2017-2022)
2.3.2 Global CD27 Antibody Revenue and Market Share by Type (2017-2022)
2.3.3 Global CD27 Antibody Sale Price by Type (2017-2022)
2.4 CD27 Antibody Segment by Application
2.4.1 Flow Cytometry
2.4.2 ELISA
2.4.3 Western Blot
2.4.4 Immunoprecipitation
2.4.5 Immunofluorescence
2.4.6 Other
2.5 CD27 Antibody Sales by Application
2.5.1 Global CD27 Antibody Sale Market Share by Application (2017-2022)
2.5.2 Global CD27 Antibody Revenue and Market Share by Application (2017-2022)
2.5.3 Global CD27 Antibody Sale Price by Application (2017-2022)
3 Global CD27 Antibody by Company
3.1 Global CD27 Antibody Breakdown Data by Company
3.1.1 Global CD27 Antibody Annual Sales by Company (2020-2022)
3.1.2 Global CD27 Antibody Sales Market Share by Company (2020-2022)
3.2 Global CD27 Antibody Annual Revenue by Company (2020-2022)
3.2.1 Global CD27 Antibody Revenue by Company (2020-2022)
3.2.2 Global CD27 Antibody Revenue Market Share by Company (2020-2022)
3.3 Global CD27 Antibody Sale Price by Company
3.4 Key Manufacturers CD27 Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CD27 Antibody Product Location Distribution
3.4.2 Players CD27 Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for CD27 Antibody by Geographic Region
4.1 World Historic CD27 Antibody Market Size by Geographic Region (2017-2022)
4.1.1 Global CD27 Antibody Annual Sales by Geographic Region (2017-2022)
4.1.2 Global CD27 Antibody Annual Revenue by Geographic Region
4.2 World Historic CD27 Antibody Market Size by Country/Region (2017-2022)
4.2.1 Global CD27 Antibody Annual Sales by Country/Region (2017-2022)
4.2.2 Global CD27 Antibody Annual Revenue by Country/Region
4.3 Americas CD27 Antibody Sales Growth
4.4 APAC CD27 Antibody Sales Growth
4.5 Europe CD27 Antibody Sales Growth
4.6 Middle East & Africa CD27 Antibody Sales Growth
5 Americas
5.1 Americas CD27 Antibody Sales by Country
5.1.1 Americas CD27 Antibody Sales by Country (2017-2022)
5.1.2 Americas CD27 Antibody Revenue by Country (2017-2022)
5.2 Americas CD27 Antibody Sales by Type
5.3 Americas CD27 Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CD27 Antibody Sales by Region
6.1.1 APAC CD27 Antibody Sales by Region (2017-2022)
6.1.2 APAC CD27 Antibody Revenue by Region (2017-2022)
6.2 APAC CD27 Antibody Sales by Type
6.3 APAC CD27 Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe CD27 Antibody by Country
7.1.1 Europe CD27 Antibody Sales by Country (2017-2022)
7.1.2 Europe CD27 Antibody Revenue by Country (2017-2022)
7.2 Europe CD27 Antibody Sales by Type
7.3 Europe CD27 Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CD27 Antibody by Country
8.1.1 Middle East & Africa CD27 Antibody Sales by Country (2017-2022)
8.1.2 Middle East & Africa CD27 Antibody Revenue by Country (2017-2022)
8.2 Middle East & Africa CD27 Antibody Sales by Type
8.3 Middle East & Africa CD27 Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of CD27 Antibody
10.3 Manufacturing Process Analysis of CD27 Antibody
10.4 Industry Chain Structure of CD27 Antibody
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 CD27 Antibody Distributors
11.3 CD27 Antibody Customer
12 World Forecast Review for CD27 Antibody by Geographic Region
12.1 Global CD27 Antibody Market Size Forecast by Region
12.1.1 Global CD27 Antibody Forecast by Region (2023-2028)
12.1.2 Global CD27 Antibody Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global CD27 Antibody Forecast by Type
12.7 Global CD27 Antibody Forecast by Application
13 Key Players Analysis
13.1 Sino Biological, Inc.
13.1.1 Sino Biological, Inc. Company Information
13.1.2 Sino Biological, Inc. CD27 Antibody Product Offered
13.1.3 Sino Biological, Inc. CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sino Biological, Inc. Main Business Overview
13.1.5 Sino Biological, Inc. Latest Developments
13.2 LifeSpan BioSciences, Inc
13.2.1 LifeSpan BioSciences, Inc Company Information
13.2.2 LifeSpan BioSciences, Inc CD27 Antibody Product Offered
13.2.3 LifeSpan BioSciences, Inc CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 LifeSpan BioSciences, Inc Main Business Overview
13.2.5 LifeSpan BioSciences, Inc Latest Developments
13.3 BioLegend
13.3.1 BioLegend Company Information
13.3.2 BioLegend CD27 Antibody Product Offered
13.3.3 BioLegend CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BioLegend Main Business Overview
13.3.5 BioLegend Latest Developments
13.4 Thermo Fisher Scientific (China) Co., Ltd.
13.4.1 Thermo Fisher Scientific (China) Co., Ltd. Company Information
13.4.2 Thermo Fisher Scientific (China) Co., Ltd. CD27 Antibody Product Offered
13.4.3 Thermo Fisher Scientific (China) Co., Ltd. CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Thermo Fisher Scientific (China) Co., Ltd. Main Business Overview
13.4.5 Thermo Fisher Scientific (China) Co., Ltd. Latest Developments
13.5 Abcam
13.5.1 Abcam Company Information
13.5.2 Abcam CD27 Antibody Product Offered
13.5.3 Abcam CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abcam Main Business Overview
13.5.5 Abcam Latest Developments
13.6 Bio-Techne
13.6.1 Bio-Techne Company Information
13.6.2 Bio-Techne CD27 Antibody Product Offered
13.6.3 Bio-Techne CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bio-Techne Main Business Overview
13.6.5 Bio-Techne Latest Developments
13.7 MyBiosource, Inc.
13.7.1 MyBiosource, Inc. Company Information
13.7.2 MyBiosource, Inc. CD27 Antibody Product Offered
13.7.3 MyBiosource, Inc. CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 MyBiosource, Inc. Main Business Overview
13.7.5 MyBiosource, Inc. Latest Developments
13.8 Merck
13.8.1 Merck Company Information
13.8.2 Merck CD27 Antibody Product Offered
13.8.3 Merck CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merck Main Business Overview
13.8.5 Merck Latest Developments
13.9 Bio-Rad Laboratories, Inc.
13.9.1 Bio-Rad Laboratories, Inc. Company Information
13.9.2 Bio-Rad Laboratories, Inc. CD27 Antibody Product Offered
13.9.3 Bio-Rad Laboratories, Inc. CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bio-Rad Laboratories, Inc. Main Business Overview
13.9.5 Bio-Rad Laboratories, Inc. Latest Developments
13.10 Arigo Biolaboratories Corp.
13.10.1 Arigo Biolaboratories Corp. Company Information
13.10.2 Arigo Biolaboratories Corp. CD27 Antibody Product Offered
13.10.3 Arigo Biolaboratories Corp. CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Arigo Biolaboratories Corp. Main Business Overview
13.10.5 Arigo Biolaboratories Corp. Latest Developments
13.11 GeneTex
13.11.1 GeneTex Company Information
13.11.2 GeneTex CD27 Antibody Product Offered
13.11.3 GeneTex CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 GeneTex Main Business Overview
13.11.5 GeneTex Latest Developments
13.12 Boster Biological Technology
13.12.1 Boster Biological Technology Company Information
13.12.2 Boster Biological Technology CD27 Antibody Product Offered
13.12.3 Boster Biological Technology CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Boster Biological Technology Main Business Overview
13.12.5 Boster Biological Technology Latest Developments
13.13 Creative Diagnostics
13.13.1 Creative Diagnostics Company Information
13.13.2 Creative Diagnostics CD27 Antibody Product Offered
13.13.3 Creative Diagnostics CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Creative Diagnostics Main Business Overview
13.13.5 Creative Diagnostics Latest Developments
13.14 OriGene Technologies, Inc.
13.14.1 OriGene Technologies, Inc. Company Information
13.14.2 OriGene Technologies, Inc. CD27 Antibody Product Offered
13.14.3 OriGene Technologies, Inc. CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 OriGene Technologies, Inc. Main Business Overview
13.14.5 OriGene Technologies, Inc. Latest Developments
13.15 Elabscience Biotechnology Inc.
13.15.1 Elabscience Biotechnology Inc. Company Information
13.15.2 Elabscience Biotechnology Inc. CD27 Antibody Product Offered
13.15.3 Elabscience Biotechnology Inc. CD27 Antibody Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Elabscience Biotechnology Inc. Main Business Overview
13.15.5 Elabscience Biotechnology Inc. Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. CD27 Antibody Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. CD27 Antibody Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Polyclonal Antibody
Table 5. Global CD27 Antibody Sales by Type (2017-2022) & (K Units)
Table 6. Global CD27 Antibody Sales Market Share by Type (2017-2022)
Table 7. Global CD27 Antibody Revenue by Type (2017-2022) & ($ million)
Table 8. Global CD27 Antibody Revenue Market Share by Type (2017-2022)
Table 9. Global CD27 Antibody Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global CD27 Antibody Sales by Application (2017-2022) & (K Units)
Table 11. Global CD27 Antibody Sales Market Share by Application (2017-2022)
Table 12. Global CD27 Antibody Revenue by Application (2017-2022)
Table 13. Global CD27 Antibody Revenue Market Share by Application (2017-2022)
Table 14. Global CD27 Antibody Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global CD27 Antibody Sales by Company (2020-2022) & (K Units)
Table 16. Global CD27 Antibody Sales Market Share by Company (2020-2022)
Table 17. Global CD27 Antibody Revenue by Company (2020-2022) ($ Millions)
Table 18. Global CD27 Antibody Revenue Market Share by Company (2020-2022)
Table 19. Global CD27 Antibody Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers CD27 Antibody Producing Area Distribution and Sales Area
Table 21. Players CD27 Antibody Products Offered
Table 22. CD27 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global CD27 Antibody Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global CD27 Antibody Sales Market Share Geographic Region (2017-2022)
Table 27. Global CD27 Antibody Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global CD27 Antibody Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global CD27 Antibody Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global CD27 Antibody Sales Market Share by Country/Region (2017-2022)
Table 31. Global CD27 Antibody Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global CD27 Antibody Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas CD27 Antibody Sales by Country (2017-2022) & (K Units)
Table 34. Americas CD27 Antibody Sales Market Share by Country (2017-2022)
Table 35. Americas CD27 Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas CD27 Antibody Revenue Market Share by Country (2017-2022)
Table 37. Americas CD27 Antibody Sales by Type (2017-2022) & (K Units)
Table 38. Americas CD27 Antibody Sales Market Share by Type (2017-2022)
Table 39. Americas CD27 Antibody Sales by Application (2017-2022) & (K Units)
Table 40. Americas CD27 Antibody Sales Market Share by Application (2017-2022)
Table 41. APAC CD27 Antibody Sales by Region (2017-2022) & (K Units)
Table 42. APAC CD27 Antibody Sales Market Share by Region (2017-2022)
Table 43. APAC CD27 Antibody Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC CD27 Antibody Revenue Market Share by Region (2017-2022)
Table 45. APAC CD27 Antibody Sales by Type (2017-2022) & (K Units)
Table 46. APAC CD27 Antibody Sales Market Share by Type (2017-2022)
Table 47. APAC CD27 Antibody Sales by Application (2017-2022) & (K Units)
Table 48. APAC CD27 Antibody Sales Market Share by Application (2017-2022)
Table 49. Europe CD27 Antibody Sales by Country (2017-2022) & (K Units)
Table 50. Europe CD27 Antibody Sales Market Share by Country (2017-2022)
Table 51. Europe CD27 Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe CD27 Antibody Revenue Market Share by Country (2017-2022)
Table 53. Europe CD27 Antibody Sales by Type (2017-2022) & (K Units)
Table 54. Europe CD27 Antibody Sales Market Share by Type (2017-2022)
Table 55. Europe CD27 Antibody Sales by Application (2017-2022) & (K Units)
Table 56. Europe CD27 Antibody Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa CD27 Antibody Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa CD27 Antibody Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa CD27 Antibody Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa CD27 Antibody Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa CD27 Antibody Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa CD27 Antibody Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa CD27 Antibody Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa CD27 Antibody Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of CD27 Antibody
Table 66. Key Market Challenges & Risks of CD27 Antibody
Table 67. Key Industry Trends of CD27 Antibody
Table 68. CD27 Antibody Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. CD27 Antibody Distributors List
Table 71. CD27 Antibody Customer List
Table 72. Global CD27 Antibody Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global CD27 Antibody Sales Market Forecast by Region
Table 74. Global CD27 Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global CD27 Antibody Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas CD27 Antibody Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas CD27 Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC CD27 Antibody Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC CD27 Antibody Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe CD27 Antibody Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe CD27 Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa CD27 Antibody Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa CD27 Antibody Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global CD27 Antibody Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global CD27 Antibody Sales Market Share Forecast by Type (2023-2028)
Table 86. Global CD27 Antibody Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global CD27 Antibody Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global CD27 Antibody Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global CD27 Antibody Sales Market Share Forecast by Application (2023-2028)
Table 90. Global CD27 Antibody Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global CD27 Antibody Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sino Biological, Inc. Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 93. Sino Biological, Inc. CD27 Antibody Product Offered
Table 94. Sino Biological, Inc. CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Sino Biological, Inc. Main Business
Table 96. Sino Biological, Inc. Latest Developments
Table 97. LifeSpan BioSciences, Inc Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 98. LifeSpan BioSciences, Inc CD27 Antibody Product Offered
Table 99. LifeSpan BioSciences, Inc CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. LifeSpan BioSciences, Inc Main Business
Table 101. LifeSpan BioSciences, Inc Latest Developments
Table 102. BioLegend Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 103. BioLegend CD27 Antibody Product Offered
Table 104. BioLegend CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. BioLegend Main Business
Table 106. BioLegend Latest Developments
Table 107. Thermo Fisher Scientific (China) Co., Ltd. Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 108. Thermo Fisher Scientific (China) Co., Ltd. CD27 Antibody Product Offered
Table 109. Thermo Fisher Scientific (China) Co., Ltd. CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Thermo Fisher Scientific (China) Co., Ltd. Main Business
Table 111. Thermo Fisher Scientific (China) Co., Ltd. Latest Developments
Table 112. Abcam Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 113. Abcam CD27 Antibody Product Offered
Table 114. Abcam CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Abcam Main Business
Table 116. Abcam Latest Developments
Table 117. Bio-Techne Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 118. Bio-Techne CD27 Antibody Product Offered
Table 119. Bio-Techne CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Bio-Techne Main Business
Table 121. Bio-Techne Latest Developments
Table 122. MyBiosource, Inc. Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 123. MyBiosource, Inc. CD27 Antibody Product Offered
Table 124. MyBiosource, Inc. CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. MyBiosource, Inc. Main Business
Table 126. MyBiosource, Inc. Latest Developments
Table 127. Merck Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 128. Merck CD27 Antibody Product Offered
Table 129. Merck CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Merck Main Business
Table 131. Merck Latest Developments
Table 132. Bio-Rad Laboratories, Inc. Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 133. Bio-Rad Laboratories, Inc. CD27 Antibody Product Offered
Table 134. Bio-Rad Laboratories, Inc. CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Bio-Rad Laboratories, Inc. Main Business
Table 136. Bio-Rad Laboratories, Inc. Latest Developments
Table 137. Arigo Biolaboratories Corp. Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 138. Arigo Biolaboratories Corp. CD27 Antibody Product Offered
Table 139. Arigo Biolaboratories Corp. CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Arigo Biolaboratories Corp. Main Business
Table 141. Arigo Biolaboratories Corp. Latest Developments
Table 142. GeneTex Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 143. GeneTex CD27 Antibody Product Offered
Table 144. GeneTex CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. GeneTex Main Business
Table 146. GeneTex Latest Developments
Table 147. Boster Biological Technology Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 148. Boster Biological Technology CD27 Antibody Product Offered
Table 149. Boster Biological Technology CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Boster Biological Technology Main Business
Table 151. Boster Biological Technology Latest Developments
Table 152. Creative Diagnostics Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 153. Creative Diagnostics CD27 Antibody Product Offered
Table 154. Creative Diagnostics CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Creative Diagnostics Main Business
Table 156. Creative Diagnostics Latest Developments
Table 157. OriGene Technologies, Inc. Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 158. OriGene Technologies, Inc. CD27 Antibody Product Offered
Table 159. OriGene Technologies, Inc. CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. OriGene Technologies, Inc. Main Business
Table 161. OriGene Technologies, Inc. Latest Developments
Table 162. Elabscience Biotechnology Inc. Basic Information, CD27 Antibody Manufacturing Base, Sales Area and Its Competitors
Table 163. Elabscience Biotechnology Inc. CD27 Antibody Product Offered
Table 164. Elabscience Biotechnology Inc. CD27 Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Elabscience Biotechnology Inc. Main Business
Table 166. Elabscience Biotechnology Inc. Latest Developments
List of Figures
Figure 1. Picture of CD27 Antibody
Figure 2. CD27 Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CD27 Antibody Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global CD27 Antibody Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. CD27 Antibody Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monoclonal Antibody
Figure 10. Product Picture of Polyclonal Antibody
Figure 11. Global CD27 Antibody Sales Market Share by Type in 2021
Figure 12. Global CD27 Antibody Revenue Market Share by Type (2017-2022)
Figure 13. CD27 Antibody Consumed in Flow Cytometry
Figure 14. Global CD27 Antibody Market: Flow Cytometry (2017-2022) & (K Units)
Figure 15. CD27 Antibody Consumed in ELISA
Figure 16. Global CD27 Antibody Market: ELISA (2017-2022) & (K Units)
Figure 17. CD27 Antibody Consumed in Western Blot
Figure 18. Global CD27 Antibody Market: Western Blot (2017-2022) & (K Units)
Figure 19. CD27 Antibody Consumed in Immunoprecipitation
Figure 20. Global CD27 Antibody Market: Immunoprecipitation (2017-2022) & (K Units)
Figure 21. CD27 Antibody Consumed in Immunofluorescence
Figure 22. Global CD27 Antibody Market: Immunofluorescence (2017-2022) & (K Units)
Figure 23. CD27 Antibody Consumed in Other
Figure 24. Global CD27 Antibody Market: Other (2017-2022) & (K Units)
Figure 25. Global CD27 Antibody Sales Market Share by Application (2017-2022)
Figure 26. Global CD27 Antibody Revenue Market Share by Application in 2021
Figure 27. CD27 Antibody Revenue Market by Company in 2021 ($ Million)
Figure 28. Global CD27 Antibody Revenue Market Share by Company in 2021
Figure 29. Global CD27 Antibody Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global CD27 Antibody Revenue Market Share by Geographic Region in 2021
Figure 31. Global CD27 Antibody Sales Market Share by Region (2017-2022)
Figure 32. Global CD27 Antibody Revenue Market Share by Country/Region in 2021
Figure 33. Americas CD27 Antibody Sales 2017-2022 (K Units)
Figure 34. Americas CD27 Antibody Revenue 2017-2022 ($ Millions)
Figure 35. APAC CD27 Antibody Sales 2017-2022 (K Units)
Figure 36. APAC CD27 Antibody Revenue 2017-2022 ($ Millions)
Figure 37. Europe CD27 Antibody Sales 2017-2022 (K Units)
Figure 38. Europe CD27 Antibody Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa CD27 Antibody Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa CD27 Antibody Revenue 2017-2022 ($ Millions)
Figure 41. Americas CD27 Antibody Sales Market Share by Country in 2021
Figure 42. Americas CD27 Antibody Revenue Market Share by Country in 2021
Figure 43. United States CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC CD27 Antibody Sales Market Share by Region in 2021
Figure 48. APAC CD27 Antibody Revenue Market Share by Regions in 2021
Figure 49. China CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 53. India CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe CD27 Antibody Sales Market Share by Country in 2021
Figure 56. Europe CD27 Antibody Revenue Market Share by Country in 2021
Figure 57. Germany CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 58. France CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa CD27 Antibody Sales Market Share by Country in 2021
Figure 63. Middle East & Africa CD27 Antibody Revenue Market Share by Country in 2021
Figure 64. Egypt CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country CD27 Antibody Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of CD27 Antibody in 2021
Figure 70. Manufacturing Process Analysis of CD27 Antibody
Figure 71. Industry Chain Structure of CD27 Antibody
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets